Recombinant humanized anti-H7N9 monoclonal antibody (Sinocelltech)
重组人源化抗H7N9单克隆抗体
Report date: 2025/06/25 16:08:31
Base Information
Drug NameRecombinant humanized anti-H7N9 monoclonal antibody (Sinocelltech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesSinoCelltech Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesSinocelltech Group LtdSinoCelltech Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A